Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
quinapril hydrochloride, Quantity: 10.85 mg (Equivalent: quinapril, Qty 10 mg)
Arrotex Pharmaceuticals Pty Ltd
quinapril hydrochloride
Tablet, film coated
Excipient Ingredients: magnesium carbonate hydrate; crospovidone; magnesium stearate; titanium dioxide; purified talc; macrogol 6000; hyprolose; isopropyl alcohol; acetone; basic butylated methacrylate copolymer
Oral
30 tablets
(S4) Prescription Only Medicine
Treatment of hypertension. It may be used alone or in combination with thiazide diuretics. Sufficient data have not been provided to support the use of quinapril in renovascular hypertension. Congestive heart failure. Adjunctive treatment of mild to moderate congestive heart failure when given concomitantly with a diuretic and/or cardiac glycoside.
Visual Identification: White to almost white, round, biconvex and one side scored film-coated tablets; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 30 Months; Container Temperature: Store below 25 degrees Celsius
Licence status A
2006-08-17